Q3 2023 Y-mAbs Therapeutics Inc Earnings Call Transcript
Good morning, and welcome to Y-mAbs Therapeutics Third Quarter 2023 Earnings Conference Call. Please note that today's event is being recorded. At this time, all participants are in a listen-only mode. Instructions for the question-and-answer session will follow the prepared remarks. I would now like to turn the conference call over to Courtney Dugan, Vice President, Investor Relations. Please go ahead.
Thank you, operator, and good morning, everyone. Welcome to our third quarter 2023 Earnings Conference Call. We issued a press release with our results yesterday at market close. The press release and accompanying slides are available on the Investor Relations section of our website.
Let me quickly remind you that the following discussion contains certain statements that are considered forward-looking statements as defined by the Private Subsidies Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about our business model and development, commercialization and product distribution plans, expectations with
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |